Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 4/20 | 0.66 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.50 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.44 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.43 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.42 |
| ▸ | MAOA | P21397 | 2/20 | 0.42 |
| ▸ | MAOB | P27338 | 2/20 | 0.42 |
| ▸ | BCHE | P06276 | 1/20 | 0.42 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.42 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.42 |
| ▸ | HTR6 | P50406 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14209228 | 1.00 | IDO1 (0.66) | IDO1PDPK1PIN1CYP11B2GPR84 | |
| SCHEMBL21300294 | 1.00 | IDO1 (0.66) | IDO1PDPK1PIN1CYP11B2GPR84 | |
| Alcohol SCHEMBL388322 | 0.91 | IDO1 (0.56) | IDO1PDPK1PIN1GPR84MAOA | |
| SCHEMBL3907558 | 0.88 | IDO1 (0.68) | IDO1PDPK1GPR84 | |
| SCHEMBL12727345 | 0.88 | IDO1 (0.68) | IDO1PDPK1GPR84 | |
| SCHEMBL31251494 | 0.88 | IDO1 (0.68) | IDO1PDPK1GPR84 | |
| SCHEMBL29518873 | 0.88 | IDO1 (0.68) | IDO1PDPK1GPR84 | |
| SCHEMBL2472307 | 0.88 | IDO1 (0.68) | IDO1PDPK1GPR84 | |
| SCHEMBL376248 | 0.83 | IDO1 (0.70) | IDO1PDPK1CYP11B2GPR84 | |
| SCHEMBL3814265 | 0.82 | IDO1 (0.46) | IDO1PDPK1PIN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11186564-B2 | Dual NAV1.2/5HT2a inhibitors for treating CNS disorders | SUNOVION PHARMACEUTICALS INC. (US) | 2021-11-30 | — | — | US | claimed |
| CN-110156577-A | A kind of synthetic method of Beta-bromo ether compound | 浙江工业大学 | 2019-08-23 | — | — | CN | claimed |
| US-20190194163-A1 | DUAL NAV1.2/5HT2a INHIBITORS FOR TREATING CNS DISORDERS | SUNOVION PHARMACEUTICALS INC. (US) | 2019-06-27 | — | — | US | claimed |
| WO-2018026371-A1 | DUAL NAV1.2/5HT2A INHIBITORS FOR TREATING CNS DISORDERS | SUNOVION PHARMACEUTICALS INC. (US) | 2018-02-08 | — | — | WO | claimed |
| CN-106632217-A | (4S, 7RS)-galaxolide synthesis method | 北京安胜瑞力科技有限公司 | 2017-05-10 | — | — | CN | claimed |
| EP-0674232-B1 | Recording sheets | XEROX CORP (US) | 2000-05-31 | — | — | EP | claimed |
| US-5082952-A | Ligand exchange | CIBA-GEIGY CORPORATION (US) | 1992-01-21 | — | — | US | claimed |
| EP-0207889-B1 | PROCESS FOR THE PREPARATION OF METALLOCENE COMPLEXES | CIBA-GEIGY AG (CH) | 1988-07-20 | — | — | EP | claimed |
| EP-0207889-A1 | Process for the preparation of metallocene complexes | CIBA-GEIGY AG (CH) | 1987-01-07 | — | — | EP | claimed |
| EP-3850680-B1 | ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2024-11-06 | — | — | EP | disclosed |
| EP-3850679-B1 | ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2024-10-09 | — | — | EP | disclosed |
| US-20240124408-A1 | Substituted Cyclohexanecarboxamides, Their Preparation and Their Therapeutic Application | SANOFI (FR) | 2024-04-18 | — | — | US | disclosed |
| CN-117567254-A | Indane ring biphenyl liquid crystal compound and preparation method and application thereof | 武汉轻工大学 | 2024-02-20 | — | — | CN | disclosed |
| CN-117510298-A | Indane ring biphenyl liquid crystal composition and application thereof | 武汉轻工大学 | 2024-02-06 | — | — | CN | disclosed |
| EP-0214103-B1 | ADHESIVELY BONDED PHOTOSTRUCTURABLE POLYIMIDE FOIL | CIBA-GEIGY AG (CH) | 1990-06-27 | — | — | EP | disclosed |
| US-4935320-A | Substrate, thermostable adhesive, self-supporting, photocrosslinkable polyimide film | CIBA-GEIGY CORPORATION (US) | 1990-06-19 | — | — | US | disclosed |
| US-4786569-A | Adhesively bonded photostructurable polyimide film | CIBA-GEIGY CORPORATION (US) | 1988-11-22 | — | — | US | disclosed |
| EP-0207889-B1 | PROCESS FOR THE PREPARATION OF METALLOCENE COMPLEXES | CIBA-GEIGY AG (CH) | 1988-07-20 | — | — | EP | disclosed |
| EP-0214103-A2 | Adhesively bonded photostructurable polyimide foil | CIBA-GEIGY AG (CH) | 1987-03-11 | — | — | EP | disclosed |
| EP-0207889-A1 | Process for the preparation of metallocene complexes | CIBA-GEIGY AG (CH) | 1987-01-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190194163-A1 | DUAL NAV1.2/5HT2a INHIBITORS FOR TREATING CNS DISORDERS | SCN2A, HTR2A, HTR2C | IDO1 724/4885PDPK1 1256/4885PIN1 3338/4885 |
| US-20240124408-A1 | Substituted Cyclohexanecarboxamides, Their Preparation and Their Therapeutic Application | TRPM8, TAS2R8, TRPM7 | IDO1 4208/4885PDPK1 2724/4885PIN1 4346/4885 |
| US-11186564-B2 | Dual NAV1.2/5HT2a inhibitors for treating CNS disorders | SCN2A, HTR2A, HTR2C | IDO1 724/4885PDPK1 1256/4885PIN1 3338/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.